These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2300925)

  • 1. Critical role of the carbohydrate moiety in human von Willebrand factor protein for interactions with type I collagen.
    Kessler CM; Floyd CM; Frantz SC; Orthner C
    Thromb Res; 1990 Jan; 57(1):59-76. PubMed ID: 2300925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of carbohydrate modifications of factor VIII/von Willebrand factor on binding to platelets.
    Goudemand J; Mazurier C; Samor B; Bouquelet S; Montreuil J; Goudemand M
    Thromb Haemost; 1985 Jun; 53(3):390-5. PubMed ID: 2864750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation.
    Federici AB; Elder JH; De Marco L; Ruggeri ZM; Zimmerman TS
    J Clin Invest; 1984 Dec; 74(6):2049-55. PubMed ID: 6239876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor VIII/von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity.
    Gralnick HR
    J Clin Invest; 1978 Aug; 62(2):496-9. PubMed ID: 307560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis.
    Stockschlaeder M; Schneppenheim R; Budde U
    Blood Coagul Fibrinolysis; 2014 Apr; 25(3):206-16. PubMed ID: 24448155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of carbohydrate in multimeric structure of factor VIII/von Willebrand factor protein.
    Gralnick HR; Williams SB; Rick ME
    Proc Natl Acad Sci U S A; 1983 May; 80(9):2771-4. PubMed ID: 6601805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two von Willebrand factor collagen-binding assays with different binding affinities for low, medium, and high multimers of von Willebrand factor.
    Neugebauer BM; Goy C; Budek I; Seitz R
    Semin Thromb Hemost; 2002 Apr; 28(2):139-48. PubMed ID: 11992237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired von Willebrand factor deficiency caused by LVAD is ADAMTS-13 and platelet dependent.
    Jilma-Stohlawetz P; Quehenberger P; Schima H; Stoiber M; Knöbl P; Steinlechner B; Felli A; Jilma B
    Thromb Res; 2016 Jan; 137():196-201. PubMed ID: 26616301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
    Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
    J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
    Turecek PL; Siekmann J; Schwarz HP
    Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of deletion of the A1 domain of von Willebrand factor on its binding to heparin, collagen and platelets in the presence of ristocetin.
    Sixma JJ; Schiphorst ME; Verweij CL; Pannekoek H
    Eur J Biochem; 1991 Mar; 196(2):369-75. PubMed ID: 1901037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-linked carbohydrate of recombinant von Willebrand factor influences ristocetin-induced binding to platelet glycoprotein 1b.
    Carew JA; Quinn SM; Stoddart JH; Lynch DC
    J Clin Invest; 1992 Dec; 90(6):2258-67. PubMed ID: 1469086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired type II von Willebrand's disease: demonstration of a complexed inhibitor of the von Willebrand factor-platelet interaction and response to treatment.
    Goudemand J; Samor B; Caron C; Jude B; Gosset D; Mazurier C
    Br J Haematol; 1988 Feb; 68(2):227-33. PubMed ID: 3126793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of a type IIB von Willebrand disease missense mutation: increased binding of large von Willebrand factor multimers to platelets.
    Cooney KA; Lyons SE; Ginsburg D
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2869-72. PubMed ID: 1557393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional domains on von Willebrand factor. Recognition of discrete tryptic fragments by monoclonal antibodies that inhibit interaction of von Willebrand factor with platelets and with collagen.
    Sixma JJ; Sakariassen KS; Stel HV; Houdijk WP; In der Maur DW; Hamer RJ; de Groot PG; van Mourik JA
    J Clin Invest; 1984 Sep; 74(3):736-44. PubMed ID: 6332119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired type 2A von Willebrand syndrome caused by aortic valve disease corrects during valve surgery.
    Solomon C; Budde U; Schneppenheim S; Czaja E; Hagl C; Schoechl H; von Depka M; Rahe-Meyer N
    Br J Anaesth; 2011 Apr; 106(4):494-500. PubMed ID: 21278152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A family having type 2B von Willebrand disease with an R1306W mutation: Severe thrombocytopenia leads to the normalization of high molecular weight multimers.
    Ozeki M; Kunishima S; Kasahara K; Funato M; Teramoto T; Kaneko H; Fukao T; Kondo N
    Thromb Res; 2010 Feb; 125(2):e17-22. PubMed ID: 19740526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desialylation of platelets induced by Von Willebrand Factor is a novel mechanism of platelet clearance in dengue.
    Riswari SF; Tunjungputri RN; Kullaya V; Garishah FM; Utari GSR; Farhanah N; Overheul GJ; Alisjahbana B; Gasem MH; Urbanus RT; de Groot PG; Lefeber DJ; van Rij RP; van der Ven A; de Mast Q
    PLoS Pathog; 2019 Mar; 15(3):e1007500. PubMed ID: 30849118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased thrombin generation and platelet activation are associated with deficiency in high molecular weight multimers of von Willebrand factor in patients with moderate-to-severe aortic stenosis.
    Natorska J; Bykowska K; Hlawaty M; Marek G; Sadowski J; Undas A
    Heart; 2011 Dec; 97(24):2023-8. PubMed ID: 21561895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.